Trial Profile
Optima: Optimizing Prograf Therapy in Maintenance Allografts II.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin
- Indications Renal transplant rejection
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Acronyms OPTIMAII
- 01 Jun 2009 New trial record